Immunohistochemical analysis of non- Hodgkin's lymphoma spectrum according to WHO/REAL classification: A single centre experience from Punjab, India

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 1, 2014, Pages 46-49

  Sharma, Manisha ^a   Mannan, Rahul ^a   Madhukar, Mohit ^a   Navani, Sanjay ^b   Manjari, Mridu ^a   Singh Bhasin, Tejinder ^a   Singh Gill, Karamjit ^a  

^a SRI GURU RAM DAS INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^b Human Protein Atlas India ^*  (India)

Author keywords

B cell lymphomas; Immunophenotyping; Non Hodgkins lymphoma; T cell lymphomas; WHO REAL classification

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CD15 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD45RO ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; LEUKOSIALIN; PROTEIN BCL 2; PROTEIN BCL 6; STEM CELL FACTOR RECEPTOR; T6 ANTIGEN; TRANSCRIPTION FACTOR SOX11;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MIDDLE AGED; NONHODGKIN LYMPHOMA; SCHOOL CHILD; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84892710043     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/8173.3988     Document Type: Article

References (24)

1. Non-Hodgkin's Lymphoma A histopathologic and prognostic evaluation. http: // www. biooncology. com/researcheducation/bcell/downloads/GA10000083900_ NHL_Primer. pdf
2. Boffetta P. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol. (2011) 22 (suppl 4): iv27-iv31.
3. Yeole BB. Trends in the incidence of Non-Hodgkin's lymphoma in India. Asian Pac J Cancer Prev. 2008 Jul-Sep; 9 (3): 433-6.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar-Apr; 61 (2): 69-90.
5. Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood. 2005 Jul 15; 106 (2): 668-72.
6. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, and Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. May 12, 2011 vol. 117 no. 19 5019-503
7. Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol Oncol. 2001; 19: 129-150
8. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008 Mar; 132 (3): 441-61.
9. Rao SI. Role of immunohistochemistry in lymphoma. Indian J Med Paediatr Oncol. 2010 Oct-Dec; 31 (4): 145-147.
10. Aggarwal D, Gupta R, Singh S, Kudesia M. Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases. Hematology. 2011 Jul; 16 (4): 195-9.
11. Kalyan K, Basu D, Soundararaghavan J. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification. Indian J Pathol Microbiol. 2006 Apr; 49 (2): 203-7.
12. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006 Jan 1; 107 (1): 265-76.
13. Roy A, Kar R, Basu D, Badhe BA. Spectrum of histopathologic diagnosis of lymph node biopsies: A descriptive study from a tertiary care center in South India over 51/2 years. Indian J Pathol Microbiol. 2013; 56: 103-8
14. Vallabhajosyula S, Baijal G, Vadhiraja B M, Fernandes DJ, Vidyasagar M S. Non-Hodgkin's lymphoma: Is India ready to incorporate recent advances in day to day practice?. J Can Res Ther. 2010; 6: 36-40.
15. Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D et al., Primary Extra Nodal Non Hodgkin Lymphoma: A 5 Year Retrospective Analysis. Asian Pacific J Cancer Prev. 2012: 13 (10), 4889-4895
16. Sengar M, Akhade A, Nair R, Menon H, Shet T, Gujral S, Sridhar E et al., A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center. Indian J Med Paediatr Oncol. 2011; 32: 197-203
17. Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T et al., Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pac J Cancer Prev. 2008 Apr-Jun; 9 (2): 229-32
18. Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol. 2000; 11 Suppl 1: 63-7
19. Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol. 2012 Jul; 26 (7): 452-6.
20. Tilly H, Dreyling M; ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May; 21 Suppl 5: v172-4.
21. Salles GA. Clinical Features, Prognosis and Treatment of Follicular Lymphoma. (ASH Education Book January 1, 2007 vol. 2007 no. 1216-225)
22. Aschebrook-Kilfoy B, Caces DB, Ollberding NJ, Smith SM, Chiu BC. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA. Leuk Lymphoma. 2013 Aug; 54 (8): 1677-83.
23. Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma. Cancer J. 2012 Sep-Oct; 18 (5): 432-8.
24. Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B et al., Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013 Jan 10; 31 (2): 240-6.